SABR metrics Oligometastatic June 16, 2022 Top Line: Can safe and effective SABR for oligometastatic cancer be translated to a regional cancer network? The Study: The…
Oligo-letdown Breast Oligometastatic June 7, 2022 Headline: Oligometastatic breast cancer does not appear to benefit from metastasis directed therapy. The Study: The randomized EA2108 trial found…
SABR-COMET’s tail’s tail Oligometastatic May 27, 2022 Top Line: What’s better than long-term outcomes from SABR-COMET? The Study: Longer-term outcomes. Again, this phase 2 trial included 99…
Good intentions Gastrointestinal Oligometastatic May 9, 2022 Top Line: Local treatment of the primary tumor site in the setting of distant disease has known advantages for cancers…
